Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 2
1998 3
2001 1
2002 10
2003 16
2004 20
2005 26
2006 43
2007 22
2008 44
2009 36
2010 57
2011 67
2012 77
2013 104
2014 99
2015 111
2016 118
2017 105
2018 113
2019 124
2020 133
2021 118
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

1,298 results
Results by year
Filters applied: . Clear all
Page 1
PD-1/PD-L1 Inhibitors in Cervical Cancer.
Liu Y, Wu L, Tong R, Yang F, Yin L, Li M, You L, Xue J, Lu Y. Liu Y, et al. Among authors: wu l. Front Pharmacol. 2019 Feb 1;10:65. doi: 10.3389/fphar.2019.00065. eCollection 2019. Front Pharmacol. 2019. PMID: 30774597 Free PMC article. Review.
Role of ferroptosis in hepatocellular carcinoma.
Nie J, Lin B, Zhou M, Wu L, Zheng T. Nie J, et al. Among authors: wu l. J Cancer Res Clin Oncol. 2018 Dec;144(12):2329-2337. doi: 10.1007/s00432-018-2740-3. Epub 2018 Aug 22. J Cancer Res Clin Oncol. 2018. PMID: 30167889 Review.
Human Genetic Determinants of Viral Diseases.
Kenney AD, Dowdle JA, Bozzacco L, McMichael TM, St Gelais C, Panfil AR, Sun Y, Schlesinger LS, Anderson MZ, Green PL, López CB, Rosenberg BR, Wu L, Yount JS. Kenney AD, et al. Among authors: wu l. Annu Rev Genet. 2017 Nov 27;51:241-263. doi: 10.1146/annurev-genet-120116-023425. Epub 2017 Aug 30. Annu Rev Genet. 2017. PMID: 28853921 Free PMC article. Review.
The Phenotypic and Genetic Spectrum of Paroxysmal Kinesigenic Dyskinesia in China.
Huang XJ, Wang SG, Guo XN, Tian WT, Zhan FX, Zhu ZY, Yin XM, Liu Q, Yin KL, Liu XR, Zhang Y, Liu ZG, Liu XL, Zheng L, Wang T, Wu L, Rong TY, Wang Y, Zhang M, Bi GH, Tang WG, Zhang C, Zhong P, Wang CY, Tang JG, Lu W, Zhang RX, Zhao GH, Li XH, Li H, Chen T, Li HY, Luo XG, Song YY, Tang HD, Luan XH, Zhou HY, Tang BS, Chen SD, Cao L. Huang XJ, et al. Among authors: wu l. Mov Disord. 2020 Aug;35(8):1428-1437. doi: 10.1002/mds.28061. Epub 2020 May 11. Mov Disord. 2020. PMID: 32392383
Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma.
Liu R, Li Y, Tian L, Shi H, Wang J, Liang Y, Sun B, Wang S, Zhou M, Wu L, Nie J, Lin B, Tang S, Zhang Y, Wang G, Zhang C, Han J, Xu B, Liu L, Gong K, Zheng T. Liu R, et al. Among authors: wu l. Cancer Lett. 2019 Feb 28;443:34-46. doi: 10.1016/j.canlet.2018.11.030. Epub 2018 Nov 29. Cancer Lett. 2019. PMID: 30503555
1,298 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page